IIT-DHAKAL-VICD-MM
Phase II
OPEN TO ACCRUAL
A Multisite, Phase II Study of Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone (VICD) Induction in Transplant-Eligible Multiple Myeloma Patients with or without Renal Insufficiency
JANSSEN-JNJ-64407564-MONTAL-2
Phase I
OPEN TO ACCRUAL
A Multi-arm Phase 1b Study of Talquetamab with Other Anticancer Therapies in Participants with Multiple Myeloma
PROTHENA-NEOD001-301
Phase III
OPEN TO ACCRUAL
A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Birtamimab Plus Standard of Care vs. Placebo Plus Standard of Care in Mayo Stage IV Subjects with Light Chain (AL) Amyloidosis